BACKGROUND: Canadian Blood Services has been conducting quality monitoring of red blood cell (RBC) components since 2005, a period spanning the implementation of semiautomated component production. The aim was to compare the quality of RBC components produced before and after this production method change. STUDY DESIGN AND METHODS: Data from 572 RBC units were analyzed, categorized by production method: Method 1, RBC units produced by manual production methods; Method 2, RBC units produced by semiautomated production and the buffy coat method; and Method 3, RBC units produced by semiautomated production and the whole blood filtration method. RBC units were assessed using an extensive panel of in vitro tests, encompassing regulated quality control criteria such as hematocrit (Hct), hemolysis, and hemoglobin (Hb) levels, as well as adenosine triphosphate, 2,3-diphosphoglycerate, extracellular K(+) and Na(+) levels, methemoglobin, p50, RBC indices, and morphology. RESULTS: Throughout the study, all RBC units met mandated Canadian Standards Association guidelines for Hb and Hct, and most (>99%) met hemolysis requirements. However, there were significant differences among RBC units produced using different methods. Hb content was significantly lower in RBC units produced by Method 2 (51.5 ± 5.6 g/unit; p < 0.001). At expiry, hemolysis was lowest in Method 2-produced RBC units (p < 0.05) and extracellular K(+) levels were lowest in units produced by Method 1 (p < 0.001). CONCLUSION: While overall quality was similar before and after the production method change, the observed differences, although small, indicate a lack of equivalency across RBC products manufactured by different methods.
BACKGROUND: Canadian Blood Services has been conducting quality monitoring of red blood cell (RBC) components since 2005, a period spanning the implementation of semiautomated component production. The aim was to compare the quality of RBC components produced before and after this production method change. STUDY DESIGN AND METHODS: Data from 572 RBC units were analyzed, categorized by production method: Method 1, RBC units produced by manual production methods; Method 2, RBC units produced by semiautomated production and the buffy coat method; and Method 3, RBC units produced by semiautomated production and the whole blood filtration method. RBC units were assessed using an extensive panel of in vitro tests, encompassing regulated quality control criteria such as hematocrit (Hct), hemolysis, and hemoglobin (Hb) levels, as well as adenosine triphosphate, 2,3-diphosphoglycerate, extracellular K(+) and Na(+) levels, methemoglobin, p50, RBC indices, and morphology. RESULTS: Throughout the study, all RBC units met mandated Canadian Standards Association guidelines for Hb and Hct, and most (>99%) met hemolysis requirements. However, there were significant differences among RBC units produced using different methods. Hb content was significantly lower in RBC units produced by Method 2 (51.5 ± 5.6 g/unit; p < 0.001). At expiry, hemolysis was lowest in Method 2-produced RBC units (p < 0.05) and extracellular K(+) levels were lowest in units produced by Method 1 (p < 0.001). CONCLUSION: While overall quality was similar before and after the production method change, the observed differences, although small, indicate a lack of equivalency across RBC products manufactured by different methods.
Authors: Ruqayyah J Almizraq; Philip J Norris; Heather Inglis; Somaang Menocha; Mathijs R Wirtz; Nicole Juffermans; Suchitra Pandey; Philip C Spinella; Jason P Acker; Jennifer A Muszynski Journal: Blood Adv Date: 2018-09-25
Authors: Olga Mykhailova; Carly Olafson; Tracey R Turner; Angelo DʼAlessandro; Jason P Acker Journal: Transfusion Date: 2020-08-19 Impact factor: 3.157
Authors: Nareg H Roubinian; Colleen Plimier; Jennifer P Woo; Catherine Lee; Roberta Bruhn; Vincent X Liu; Gabriel J Escobar; Steven H Kleinman; Darrell J Triulzi; Edward L Murphy; Michael P Busch Journal: Blood Date: 2019-07-26 Impact factor: 22.113
Authors: Tamir Kanias; Derek Sinchar; David Osei-Hwedieh; Jeffrey J Baust; Andrew Jordan; James C Zimring; Hayley R Waterman; Karen S de Wolski; Jason P Acker; Mark T Gladwin Journal: Transfusion Date: 2016-08-09 Impact factor: 3.157
Authors: Beatriz Bicalho; Katherine Serrano; Alberto Dos Santos Pereira; Dana V Devine; Jason P Acker Journal: Transfus Med Hemother Date: 2015-10-29 Impact factor: 3.747
Authors: Jaroslav G Vostal; Paul W Buehler; Monique P Gelderman; Abdu I Alayash; Alan Doctor; James C Zimring; Simone A Glynn; John R Hess; Harvey Klein; Jason P Acker; Philip C Spinella; Angelo D'Alessandro; Bernhard Palsson; Thomas J Raife; Michael P Busch; Timothy J McMahon; Marcos Intaglietta; Harold M Swartz; Michael A Dubick; Sylvain Cardin; Rakesh P Patel; Charles Natanson; John W Weisel; Jennifer A Muszynski; Philip J Norris; Paul M Ness Journal: Transfusion Date: 2017-12-15 Impact factor: 3.157